SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-582025
Filing Date
2016-05-06
Accepted
2016-05-06 16:16:55
Documents
3
Effectiveness Date
2016-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 d187899ds8.htm S-8 59680
2 EX-5.1 d187899dex51.htm EX-5.1 4656
3 EX-23.1 d187899dex231.htm EX-23.1 1395
  Complete submission text file 0001193125-16-582025.txt   66763
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-211200 | Film No.: 161628252
SIC: 2835 In Vitro & In Vivo Diagnostic Substances